New DOT Drug test regimen goes into effect

Oct 25, 2010 - 6:02 am


The Department of Transportation has enacted changes to the DOT compliance drug test regimen effective October 1st, 2010.  While the drug test is still a 5 panel regimen, it will include new testing for HDMA (Esctasy) and lower cut off levels for amphetamines and cocaine.    The U.S. Department of Health and Human Services estimates that as much as 10 percent additional users of cocaine and amphetamines will be identified with the lower testing amounts.

The DOT drug test will continue to test for following 5-panels Marijuana (THC), Cocaine, Amphetamines, Opiates, and Phencyclidine (PCP).   To the amphetamines group, the DOT is adding initial testing for MDMA (Ecstasy) and confirmatory testing for MDMA, MDA, & MDEA.

It should be interesting to see what happens across the transportation industry due to the lower result levels for amphetamines.  While the new drug Ecstasy might not be a drug of choice among drivers, the allure of using amphetamines to help keep going on a long haul is much more industry relevant.

Need to establish a DOT-drug testing program?  Contact Corra Group, a nationwide provider of DOT drug testing compliance programs, including DOT employment verifications, DOT Physical exams, and random drug testing management.

Leave a Comment

If you would like to make a comment, please fill out the form below.

You must be logged in to post a comment.

Need Employment Background Checks? Visit Corragroup.com, the premiere service for employment screening solutions.

© 2017 Safeguard Screening All Rights Reserved.